有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(1R)-1-[(5-cyclopropyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-phenyl-1,3,4-oxadiazole | —— | C18H19N5OS |
|
—— | ethyl (1S)-2-oxo-1-[2-[[4-(2-thiophen-2-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]cyclopentane-1-carboxylate | —— | C18H23N3O3S2 |
|
—— | N-[(R)-(4-fluorophenyl)-thiophen-2-ylmethyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C17H14FN3OS2 |
|
—— | (2R)-2-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-(2-thiophen-2-ylethyl)propanamide | —— | C16H18N4O2S2 |
|
—— | 3-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanyl]-N-[(5S)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl]propanamide | —— | C17H22N4OS |
|
—— | N-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C19H23N3O3S |
|
—— | N-[2-(2-methylphenyl)ethyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C15H17N3OS |
|
—— | N-[(1R)-1-(furan-2-yl)ethyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C12H13N3O2S |
|
—— | 2-(5-Bromothiophen-2-yl)-5-(pyrimidin-2-ylsulfanylmethyl)-1,3,4-oxadiazole | —— | C11H7BrN4OS2 |
|
—— | N-[(3S)-1,1-dioxothiolan-3-yl]-N-(2-methoxyethyl)-2-pyrimidin-2-ylsulfanylacetamide | —— | C13H19N3O4S2 |
|
—— | [2-[2-(4-Bromophenyl)sulfanylethylamino]-2-oxoethyl] 2-cyclopentylacetate | —— | C17H22BrNO3S |
|
—— | N-[3-(N-methylanilino)propyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C16H20N4OS |
|
—— | N-[2-(3-chlorophenyl)ethyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C14H14ClN3OS |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-N-[[(2S)-oxolan-2-yl]methyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C20H26N4O2S |
|
—— | N-[(2-fluorophenyl)methyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C13H12FN3OS |
|
—— | 1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-2-pyrimidin-2-ylsulfanylethanone | —— | C17H17N3OS |
|
—— | 3-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanyl]-N-[(5R)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl]propanamide | —— | C17H22N4OS |
|
—— | N-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-N-cyclopropyl-2-pyrimidin-2-ylsulfanylacetamide | —— | C18H16ClN5O2S |
|
—— | N-[(R)-phenyl(thiophen-2-yl)methyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C17H15N3OS2 |
|
—— | (2R)-2-methylsulfonylbutane | —— | C5H12O2S |
|
—— | N-[(1S)-1-(furan-2-yl)ethyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C12H13N3O2S |
|
—— | 1-Methyl-2-[[3-[(1-methylimidazol-2-yl)sulfanylmethyl]phenyl]methylsulfanyl]imidazole | —— | C16H18N4S2 |
|
—— | N-[4-(2-methylbutan-2-yl)cyclohexyl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C17H29N3OS |
|
—— | 2-(1-methylimidazol-2-yl)sulfanyl-N-[(S)-phenyl(thiophen-2-yl)methyl]acetamide | —— | C17H17N3OS2 |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C15H20N4OS |
|
—— | N-[(S)-(4-fluorophenyl)-thiophen-2-ylmethyl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C17H16FN3OS2 |
|
—— | N-[(3S)-1,1-dioxothiolan-3-yl]-N-(2-methoxyethyl)-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C13H21N3O4S2 |
|
—— | N-[[5-(4-chlorophenyl)furan-2-yl]methyl]-N-methyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C18H18ClN3O2S |
|
—— | 5-(Furan-2-yl)-3-[(1-methylimidazol-2-yl)sulfanylmethyl]-1,2-oxazole | —— | C12H11N3O2S |
|
—— | N-benzyl-2-(1-methylimidazol-2-yl)sulfanyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | —— | C20H22N4OS2 |
|
—— | N-[(R)-(4-fluorophenyl)-thiophen-2-ylmethyl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C17H16FN3OS2 |
|
—— | N-benzyl-N-(furan-2-ylmethyl)-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C18H19N3O2S |
|
—— | N-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-N-cyclopropyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C18H18ClN5O2S |
|
—— | 2-[(1-Methylimidazol-2-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,3,4-oxadiazole | —— | C14H14N4OS |
|
—— | N-benzyl-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C17H19N3O3S2 |
|
—— | N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C16H24N6O3S |
|
—— | (3R)-N-[2-(3-propan-2-yl-1,2,4-triazol-4-yl)ethyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C16H20N4OS |
|
—— | 2-(1-methylimidazol-2-yl)sulfanyl-1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)ethanone | —— | C17H19N3OS |
|
—— | (3S)-N-[2-(3-propan-2-yl-1,2,4-triazol-4-yl)ethyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C16H20N4OS |
|
—— | 2-(1-methylimidazol-2-yl)sulfanyl-N-propyl-N-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)methyl]acetamide | —— | C16H19N5O2S2 |
|
—— | 2-(2-chlorophenyl)sulfanyl-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)ethanone | —— | C17H15ClO3S |
|
—— | 2-(2-chlorophenyl)sulfanyl-N-[(2-fluorophenyl)methyl]acetamide | —— | C15H13ClFNOS |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)ethanone | —— | C15H16N4OS2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(5-chlorothiophen-2-yl)methyl]-N-ethylacetamide | —— | C11H13ClN4OS3 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-benzyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | —— | C18H19N5OS3 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[[4-(dimethylamino)phenyl]methyl]-N-methylacetamide | —— | C14H19N5OS2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-benzyl-N-(2-methoxyethyl)acetamide | —— | C14H18N4O2S2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]acetamide | —— | C17H22N4O3S2 |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-benzyl-N-(furan-2-ylmethyl)acetamide | —— | C16H16N4O2S2 |
|
—— | 2-[(5-Amino-1,3,4-thiadiazol-2-yl)sulfanyl]-1-(azocan-1-yl)ethanone | —— | C11H18N4OS2 |
|